Physician Assistant Program year 2021 Source: CMS Open Payments, 2026 publication

Lori Lafayette

Physician Assistant Wapello, IA Physician Assistant

NPI 1568476349 CMS profile 10565379

220 Mulberry St Ste A, Wapello, IA 52653

Open in the dashboard

General payments

$14

1 record reported · program year 2021

Research payments

$0

Paid to them · None reported · program year 2021

Ownership & investment interest

$0

None reported

Through program year 2021, Lori Lafayette of Wapello, IA is reported in the CMS Open Payments database as having received $14 across 1 general payment and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 1st percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

1 row
Year Kind Relative to this record's peak year Amount Records
2021 General $14 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lori Lafayette
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Lori Lafayette were reported at $0. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Lori Lafayette Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $14 $132 $37–$438 $132
2022 $0 $155 $48–$522 $149
2023 $0 $167 $52–$557 $160
2024 $0 $178 $55–$600 $164
2025 $0 $184 $57–$620 $169

Breakdown

Who paid General payments · program year 2021
  1. Amgen Inc. $14 1 payment

Every payment, record by record

What the payments were for General payments · program year 2021
  1. Education $14 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 154 drugs

Part D claims

8,357

Median for Physician Assistant: 241

Drug cost

$573,112

Median for Physician Assistant: $4,110

Branded share of claims

20.9%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 137 $91,830
Jardiance Empagliflozin Brand 83 $64,902
Trulicity Dulaglutide Brand 37 $46,394
Xarelto Rivaroxaban Brand 31 $30,738
Ozempic Semaglutide Brand 30 $30,297
Soliqua 100-33 Insulin Glargine/Lixisenatide Brand 32 $27,034
Mounjaro Tirzepatide Brand 21 $23,199
Toujeo Solostar Insulin Glargine,hum.Rec.Anlog Brand 36 $22,070
Trelegy Ellipta Fluticasone/Umeclidin/Vilanter Brand 28 $18,349
Tresiba Flextouch U-200 Insulin Degludec Brand 22 $18,062

The 10 drugs with the highest cost, of 154 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Records

1 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Iowa

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2021

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record